| ACC | American College of Cardiology |
| AHA | American Heart Association |
| BARC | Bleeding Academic Research Consortium |
| CI | Confidence interval |
| CMRi | Cardiac magnetic resonance imaging |
| DCM | Dilated cardiomyopathy |
| DOAC | Direct oral anticoagulant |
| ESC | European Society of Cardiology |
| GUSTO | Global Use of Streptokinase and t-PA for Occluded Coronary Arteries |
| HF | Heart failure |
| LVT | Left ventricular thrombus |
| meta-analysis | Meta-analysis |
| MACE | Major adverse cardiovascular events |
| MeSH | Medical Subject Headings |
| MI | Myocardial infarction |
| NOS | Newcastle–Ottawa Scale |
| OR | Odds ratio |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| RCT | Randomized clinical trial |
| RoB 2 | Risk-of-Bias 2 |
| STEMI | ST segment elevation myocardial infarction |
| TE | Thromboembolic events |
| TIA | Transient ischemic attack |
| TTE | Transthoracic echocardiography |
| TTR | Time to achieve therapeutic range |
| VKA | Vitamin K antagonist |